{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:48:44Z","timestamp":1790423324461,"version":"4.1.0"},"reference-count":55,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n The US is experiencing a protracted drug overdose crisis primarily associated with exposure to illicitly manufactured fentanyl (IMF), methamphetamine, and cocaine. Overdose risk and treatment responses may be directly affected by absolute drug exposure concentrations and drug use prevalence.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To quantify changes in absolute drug exposure concentrations from 2013 to 2023.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cross-sectional study analyzed urine drug testing (UDT) results from urine specimens collected between January 1, 2013, and August 22, 2023, in 49 states and the District of Columbia. Urine specimens were obtained from patients aged 18 years or older who presented to substance use disorder treatment clinics. The UDT was ordered by clinicians based on medical necessity.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Urine specimens were analyzed for the following drugs or metabolites (analytes tested in parentheses): fentanyl (fentanyl), heroin (6-monoacetylmorphine), cocaine (benzoylecgonine), and methamphetamine (methamphetamine) using liquid chromatography with tandem mass spectrometry.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Relative concentrations of fentanyl, heroin, cocaine, and methamphetamine. Creatinine-normalized drug concentration values were log-transformed prior to visualization and statistical analyses. The Mann-Kendall trend test was performed to examine trends over time. To estimate the geospatial and temporal patterns of drug concentration, a second series of models (1 for each drug) with an interaction effect for clinic location and collection year were fit.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 921\u202f931 unique UDT samples were collected from patients (549\u202f042 males [59.6%]; median [IQR] age, 34 [27-44] years). The adjusted fentanyl concentration in urine specimens was 38.23 (95% CI, 35.93-40.67) ng\/mg creatinine in 2023 and 4.61 (95% CI, 3.59-5.91) ng\/mg creatinine in 2013. The adjusted methamphetamine concentration was 3461.59 (95% CI, 3271.88-3662.30) ng\/mg creatinine in 2023 and 665.27 (95% CI, 608.51-727.32) ng\/mg creatinine in 2013. The adjusted cocaine concentration was 1122.23 (95% CI, 1032.41-1219.87) ng\/mg creatinine in 2023 and 559.71 (95% CI, 524.69-597.06) ng\/mg creatinine in 2013. The adjusted heroin concentration was 58.36 (95% CI, 48.26-70.58) ng\/mg creatinine in 2023 and 146.59 (95% CI, 136.06-157.92) ng\/mg creatinine in 2013. Drug concentrations varied across US Census divisions.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This cross-sectional study found that absolute concentrations of fentanyl, methamphetamine, and cocaine in urine specimens increased from 2013 to 2023, with a decrease in heroin concentration during that period. The findings suggest that exposure to these substances, as well as the illicit drug supply, has fundamentally changed in many parts of the US, highlighting the need to reinforce surveillance initiatives and accelerate efforts to treat individuals with IMF and\/or stimulant exposure.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.41063","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T11:32:01Z","timestamp":1729769521000},"page":"e2441063","source":"Crossref","is-referenced-by-count":19,"title":["Fentanyl, Heroin, Methamphetamine, and Cocaine Analyte Concentrations in Urine Drug Testing Specimens"],"prefix":"10.1001","volume":"7","author":[{"given":"Andrew S.","family":"Huhn","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penn","family":"Whitley","sequence":"additional","affiliation":[{"name":"Millennium Health, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Levi","family":"Bolin","sequence":"additional","affiliation":[{"name":"Millennium Health, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E.","family":"Dunn","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"zoi241189r1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.08.029","article-title":"Twin epidemics: the surging rise of methamphetamine use in chronic opioid users.","volume":"193","author":"Ellis","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"zoi241189r2","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/jamapsychiatry.2021.2588","article-title":"Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among US adults.","volume":"78","author":"Han","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"zoi241189r3","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2021.106950","article-title":"Trends and correlates of cocaine use among adults in the United States, 2006-2019.","volume":"120","author":"Mustaquim","year":"2021","journal-title":"Addict Behav"},{"issue":"12","key":"zoi241189r4","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1111\/add.16318","article-title":"Charting the fourth wave: geographic, temporal, race\/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021.","volume":"118","author":"Friedman","year":"2023","journal-title":"Addiction"},{"issue":"11","key":"zoi241189r5","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41386-023-01601-8","article-title":"Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis.","volume":"48","author":"Butelman","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"zoi241189r6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr Opin Psychiatry"},{"key":"zoi241189r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103791","article-title":"The practice and embodiment of \u201cgoofballs\u201d: a qualitative study exploring the co-injection of methamphetamines and opioids.","volume":"107","author":"Ivsins","year":"2022","journal-title":"Int J Drug Policy"},{"key":"zoi241189r8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.drugpo.2017.05.050","article-title":"Today\u2019s fentanyl crisis: prohibition\u2019s iron law, revisited.","volume":"46","author":"Beletsky","year":"2017","journal-title":"Int J Drug Policy"},{"key":"zoi241189r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.209028","article-title":"Predictors of opioid overdose during the COVID-19 pandemic: the role of relapse, treatment access and nonprescribed buprenorphine\/naloxone.","volume":"149","author":"Kline","year":"2023","journal-title":"J Subst Use Addict Treat"},{"issue":"1","key":"zoi241189r10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/02791072.2022.2160391","article-title":"\u201cIt\u2019s also pushed people to a new level of desperation:\u201d COVID-19 impacts on experiences of persons who use illicit opioids.","volume":"56","author":"Sweeney","year":"2024","journal-title":"J Psychoactive Drugs"},{"issue":"2","key":"zoi241189r11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.15288\/jsad.21-00438","article-title":"COVID-19-related changes to drug-selling networks and their effects on people who use illicit opioids.","volume":"84","author":"Frank","year":"2023","journal-title":"J Stud Alcohol Drugs"},{"issue":"1","key":"zoi241189r12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1176\/appi.ps.202100689","article-title":"Changes in the street prices of prescription opioids during the COVID-19 pandemic.","volume":"74","author":"Mutter","year":"2023","journal-title":"Psychiatr Serv"},{"issue":"S1","key":"zoi241189r13","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1089\/pop.2020.0230","article-title":"The opioid epidemic within the COVID-19 pandemic: drug testing in 2020.","volume":"24","author":"Niles","year":"2021","journal-title":"Popul Health Manag"},{"issue":"7","key":"zoi241189r14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.22303","article-title":"Trends in opioid toxicity-related deaths in the US before and after the start of the COVID-19 pandemic, 2011-2021.","volume":"6","author":"Gomes","year":"2023","journal-title":"JAMA Netw Open"},{"key":"zoi241189r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104212","article-title":"Negative changes in illicit drug supply during COVID-19: associations with use of overdose prevention and health services among women sex workers who use drugs (2020-2021).","volume":"121","author":"Moreheart","year":"2023","journal-title":"Int J Drug Policy"},{"issue":"1","key":"zoi241189r16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12954-024-00976-1","article-title":"The influence of transformations in supply on methamphetamine initiation among people injecting opioids in the United States.","volume":"21","author":"Mars","year":"2024","journal-title":"Harm Reduct J"},{"key":"zoi241189r17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.110985","article-title":"Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking services.","volume":"252","author":"Wagner","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"zoi241189r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2021.106540","article-title":"Changes in drug use in European cities during early COVID-19 lockdowns: a snapshot from wastewater analysis.","volume":"153","author":"Been","year":"2021","journal-title":"Environ Int"},{"issue":"4","key":"zoi241189r19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13181-021-00853-4","article-title":"\u201cWaste not, want not\u201d\u2014leveraging sewer systems and wastewater-based epidemiology for drug use trends and pharmaceutical monitoring.","volume":"17","author":"Erickson","year":"2021","journal-title":"J Med Toxicol"},{"key":"zoi241189r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.watres.2023.120452","article-title":"Monitoring medication and illicit drug consumption in a prison by wastewater-based epidemiology: impact of COVID-19 restrictions.","volume":"244","author":"Wang","year":"2023","journal-title":"Water Res"},{"issue":"5152","key":"zoi241189r22","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2013-2017.","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"zoi241189r23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jpeds.2015.04.071","article-title":"Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: a national study.","volume":"167","author":"Cerd\u00e1","year":"2015","journal-title":"J Pediatr"},{"issue":"12","key":"zoi241189r24","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1093\/aje\/kwab192","article-title":"Spatiotemporal analysis of the association between pain management clinic laws and opioid prescribing and overdose deaths.","volume":"190","author":"Cerd\u00e1","year":"2021","journal-title":"Am J Epidemiol"},{"issue":"5","key":"zoi241189r25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1176\/appi.ajp.20230918","article-title":"Harm reduction for opioid use disorder: strategies and outcome metrics.","volume":"181","author":"Ellis","year":"2024","journal-title":"Am J Psychiatry"},{"issue":"1","key":"zoi241189r26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/ADM.0000000000001013","article-title":"Opioid use disorder treatment in the fentanyl era.","volume":"17","author":"Varshneya","year":"2023","journal-title":"J Addict Med"},{"key":"zoi241189r27","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108761","article-title":"Describing the changing relationship between opioid prescribing rates and overdose mortality: a novel county-level metric.","volume":"225","author":"Hall","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"zoi241189r28","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108321","article-title":"Opioid-related overdose mortality in the era of fentanyl: monitoring a shifting epidemic by person, place, and time.","volume":"216","author":"Althoff","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"zoi241189r29","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1097\/ADM.0000000000000922","article-title":"Evidence of buprenorphine-precipitated withdrawal in persons who use fentanyl.","volume":"16","author":"Varshneya","year":"2022","journal-title":"J Addict Med"},{"key":"zoi241189r30","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108286","article-title":"Introducing NIDA\u2019s new national drug early warning system.","volume":"217","author":"Cottler","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"zoi241189r31","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/jamapsychiatry.2020.4321","article-title":"Methamphetamine overdose deaths in the US by sex and race and ethnicity.","volume":"78","author":"Han","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"474","key":"zoi241189r32","first-page":"1","article-title":"Co-involvement of opioids in drug overdose deaths involving cocaine and psychostimulants, 2011-2021.","author":"Spencer","year":"2023","journal-title":"NCHS Data Brief"},{"issue":"1","key":"zoi241189r33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/add.16334","article-title":"Associations between stimulant use and return to illicit opioid use following initiation onto medication for opioid use disorder.","volume":"119","author":"Foot","year":"2024","journal-title":"Addiction"},{"key":"zoi241189r34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jpsychires.2023.05.018","article-title":"The impact of opioid-stimulant co-use on tonic and cue-induced craving.","volume":"164","author":"Hochheimer","year":"2023","journal-title":"J Psychiatr Res"},{"key":"zoi241189r35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11469-023-01098-8","article-title":"The impact of longitudinal substance use patterns on the risk of opioid agonist therapy discontinuation: a repeated measures latent class analysis.","author":"Cui","year":"2023","journal-title":"Int J Ment Health Addict"},{"key":"zoi241189r36","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.784229","article-title":"Adults with opioid and methamphetamine co-use have lower odds of completing short-term residential treatment than other opioid co-use groups: a retrospective health services study.","volume":"12","author":"Ware","year":"2021","journal-title":"Front Psychiatry"},{"key":"zoi241189r37","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2024.100223","article-title":"Psychostimulant drug co-ingestion in non-fatal opioid overdose.","volume":"10","author":"Shastry","year":"2024","journal-title":"Drug Alcohol Depend Rep"},{"issue":"1","key":"zoi241189r38","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1080\/08897077.2021.2010252","article-title":"The need for multiple naloxone administrations for opioid overdose reversals: a review of the literature.","volume":"43","author":"Abdelal","year":"2022","journal-title":"Subst Abus"},{"issue":"1","key":"zoi241189r39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12954-022-00627-3","article-title":"Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders.","volume":"19","author":"Abdelal","year":"2022","journal-title":"Harm Reduct J"},{"key":"zoi241189r40","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.111062","article-title":"Examination of naloxone dosing patterns for opioid overdose by emergency medical services in Kentucky during increased fentanyl use from 2018 to 2021.","volume":"255","author":"Rock","year":"2024","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi241189r41","doi-asserted-by":"publisher","DOI":"10.1002\/emp2.12880","article-title":"Precipitated opioid withdrawal after buprenorphine administration in patients presenting to the emergency department: a case series.","volume":"4","author":"Spadaro","year":"2023","journal-title":"J Am Coll Emerg Physicians Open"},{"issue":"6","key":"zoi241189r42","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1080\/10826084.2024.2306221","article-title":"Characterizing opioid withdrawal experiences and consequences among a community sample of people who use opioids.","volume":"59","author":"Simpson","year":"2024","journal-title":"Subst Use Misuse"},{"issue":"1","key":"zoi241189r43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/ajad.13069","article-title":"Method for successfully inducting individuals who use illicit fentanyl onto buprenorphine\/naloxone.","volume":"30","author":"Antoine","year":"2021","journal-title":"Am J Addict"},{"issue":"6","key":"zoi241189r44","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.annemergmed.2022.05.032","article-title":"A neuropharmacological model to explain buprenorphine induction challenges.","volume":"80","author":"Greenwald","year":"2022","journal-title":"Ann Emerg Med"},{"issue":"3","key":"zoi241189r45","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.1572","article-title":"High-dose buprenorphine initiation in the emergency department among patients using fentanyl and other opioids.","volume":"6","author":"Snyder","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi241189r46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.annemergmed.2018.11.032","article-title":"Managing opioid withdrawal in the emergency department with buprenorphine.","volume":"73","author":"Herring","year":"2019","journal-title":"Ann Emerg Med"},{"issue":"6","key":"zoi241189r47","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S2215-0366(23)00095-0","article-title":"Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies.","volume":"10","author":"Degenhardt","year":"2023","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"zoi241189r48","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/ADM.0000000000001281","article-title":"Novel uses of methadone under the \u201c72-hour rule\u201d to facilitate transitions of care and low-dose buprenorphine induction in an outpatient bridge clinic.","volume":"18","author":"Shahlapour","year":"2024","journal-title":"J Addict Med"},{"issue":"9","key":"zoi241189r49","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.34540","article-title":"Buprenorphine dose and time to discontinuation among patients with opioid use disorder in the era of fentanyl.","volume":"6","author":"Chambers","year":"2023","journal-title":"JAMA Netw Open"},{"key":"zoi241189r50","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1346109","article-title":"Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids.","volume":"12","author":"Dahan","year":"2024","journal-title":"Front Public Health"},{"issue":"5","key":"zoi241189r51","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/ADM.0000000000001185","article-title":"Fentanyl absorption, distribution, metabolism, and excretion: narrative review and clinical significance related to illicitly manufactured fentanyl.","volume":"17","author":"Bird","year":"2023","journal-title":"J Addict Med"},{"key":"zoi241189r52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/SERIES1767","article-title":"How toxic is cocaine?","volume":"166","author":"Benowitz","year":"1992","journal-title":"Ciba Found Symp"},{"issue":"12","key":"zoi241189r53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015269","article-title":"Distribution and pharmacokinetics of methamphetamine in the human body: clinical implications.","volume":"5","author":"Volkow","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"zoi241189r54","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","article-title":"A review of the clinical pharmacology of methamphetamine.","volume":"104","author":"Cruickshank","year":"2009","journal-title":"Addiction"},{"issue":"10324","key":"zoi241189r55","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0140-6736(21)02252-2","article-title":"Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.","volume":"399","author":"Humphreys","year":"2022","journal-title":"Lancet"},{"key":"zoi241189r21","volume-title":"Fundamentals of Clinical Chemistry","author":"Tietz","year":"1976"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2825298\/huhn_2024_oi_241189_1731526463.56099.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T11:06:13Z","timestamp":1732014373000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2825298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.41063","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]}}}